Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EORTC CLTF 2021 | Prognostic factors for AITL

Marta Rodriguez-Moreno, Instituto de Investigación Sanitaria, Fundación Jiménez Díaz University Hospital, Madrid, Spain, outlines prognostic markers for angioimmunoblastic T-cell lymphoma (AITL), a peripheral T-cell lymphoma (PTCL) subtype. Dr Rodriguez-Moreno reports that expression of B-cell markers including ICOS and CXCL13 is correlated with a poor prognosis in patients with AITL. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.